Home › NDC Lookup › Ingredients › Bethanechol Chloride › 00832-0513-00
⚪image loading
(from DailyMed)

Bethanechol Chloride 50 mg Tablet, 100-count — NDC 0832-0513-00 (Billing 00832-0513-00)

by Upsher-Smith Laboratories, LLC · 100 TABLET in 1 BOTTLE

This is a package of 100 tablets of Bethanechol Chloride 50 mg Tablet from Upsher-Smith Laboratories, LLC, marketed since Jan 2010 and currently FDA-listed; retail pharmacies pay about $0.2704 per tablet (NADAC). It is the main listing for this product, which comes in 4 package sizes.

NDC 00832-0513-00
🏷️ FDA NDC (as labeled) 0832-0513-00 billing pads the labeler segment with a zero
This package
Contains100-count Cost per ea$0.2704 NADAC Per package$27.04 / 100 tablets Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.5115/unit · Part D plans $0.1993/unit — full pricing hub ↓
Main listing for product 0832-0513 · Also comes in: 100 tablets 0832-0513-01 500 tablets 0832-0513-50 1000 tablets 0832-0513-10
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0832-0513-00 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
0832 labeler · 0513 product · 00 package
Package marketed since
Jan 24, 2010
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 0832051300 3
Medicaid fills, this package
2,044 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0832-0513-00
Product NDC 0832-0513
11-digit billing NDC 00832051300
NCPDP billing unit EA — each (per item)
Application # ANDA040636
SPL Set ID 4e037f1e-225e-4270-8967-088c8af3a1a8
Established class (EPC) Cholinergic Muscarinic Agonist
Mechanism of action Cholinergic Muscarinic Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2010-01-24
Route ORAL
Dosage form TABLET
Substance BETHANECHOL CHLORIDE
TE code (Orange Book) AA · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 004743
GCN 18354
HICL code 001978
Ingredient (HICL) Bethanechol Chloride
HIC1 code J
Therapeutic class — broad (HIC1) Autonomic Nervous System
HIC2 code J1
Therapeutic class — intermediate (HIC2) Cholinergics
HIC3 code J1A
Therapeutic class — specific (HIC3) Parasympathetic Agents
AHFS code 12:04.00.00
AHFS class Parasympathomimetic (Cholinergic Agents)
FDB label name BETHANECHOL 50 MG TABLET
FDB brand name Bethanechol Chloride
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 004743
  • GCN: 18354
  • HICL (First Databank): 001978
  • AHFS class code: 12:04.00.00
Why two NDCs? The FDA registers this code as 0832-0513-00 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00832-0513-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name BETHANECHOL 50 MG TABLET Ingredient Bethanechol Chloride
📖 What it is MedlinePlus · NLM

Bethanechol is used to relieve difficulties in urinating caused by surgery, drugs, or other factors. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It helps you empty your bladder when it isn’t contracting well. It is used after surgery or childbirth when nothing is blocking urine flow, and for a weak bladder caused by a nerve...
  • Take it by mouth, usually three or four times a day, as your prescriber directs. Try to take it on an empty stomach, because taking it soon after a meal can cause nausea and vomiti...
  • Sometimes you’ll notice an effect within 30 minutes. More often it takes 60 to 90 minutes to work best, and the effect lasts about an hour.
  • Side effects are uncommon with tablets, but you might get stomach cramps, nausea, diarrhea, extra saliva, flushing, sweating or headache. They are more likely as the dose goes up....
📖 Read our full Bethanechol guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.270 $27.04 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.5115 $51.15 / 100 tablets
Medicare drug plans payPart D · Q2 2026 $0.1993 $19.93 / 100 tablets
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Aug 2022 Jan 2026 Sep 2026 $0.588 $0.246
▼ Down 54% over the last 23 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00832-0513-00 You're viewing this Main listing 100 TABLET in 1 BOTTLE $0.2704 / ea $27.04 2010-01-24 — Active
00832-0513-01 0832-0513-01 100 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK $0.2461 / ea $24.61 2010-01-24 — Active
00832-0513-10 0832-0513-10 1000 TABLET in 1 BOTTLE — — 2010-01-24 — Active
00832-0513-50 0832-0513-50 500 TABLET in 1 BOTTLE — — 2010-01-24 — Active

Per ea, this pack runs about 10% above the cheapest pack (NDC 00832-0513-01, $0.2461 vs $0.2704 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet in 1 bottle.
How does this package differ from NDC 00832-0513-01?
Both are Bethanechol Chloride 50 mg Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 00832-0513-01 is the 100 tablets package. Per-ea NADAC also differs: $0.2704 here vs $0.2461 for the 100 tablets pack.
What NDC number is used to bill for this package of Bethanechol Chloride 50 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bethanechol Chloride 50 mgthis 00832-0513-00 Upsher-Smith 100 tablets $0.270 AA Availability likely —
Bethanechol Chloride 50 mg 23155-0937-01 Heritage 100 tablets $0.270 AA Availability likely —
Bethanechol Chloride 50 mg 53746-0574-01 Amneal 100 tablets $0.270 AA Availability likely —
Bethanechol Chloride 50 mg 62135-0758-12 Chartwell 120 tablets $0.270 AA Availability likely —
Bethanechol Chloride 50 mg 65162-0574-10 Amneal 100 tablets $0.270 AA Availability likely —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2010
On the market since
Jan 2010
📍
2026
Currently FDA-listed
16 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Bethanechol inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerUpsher-Smith Laboratories, LLC
Application holderUPSHER SMITH LABORATORIES LLC
FDA applicationANDA040636 (ANDA)
Labeler code00832
First marketedJan 2010
Product typeHuman Prescription Drug
Portfolio229 products on file

More NDCs from Upsher-Smith Laboratories, LLC labeler code 00832

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
2K
Units reimbursed last 4 qtrs
184.4K
Gross reimbursed last 4 qtrs
$94.3K
Avg / prescription
$46.14
Avg / unit
$0.5115
Latest quarter Q1 2026
198Rx
Medicaid pays / ea
$0.5115
gross reimbursed
vs
NADAC / ea
$0.2704
acquisition cost
=
Spread
+$0.2411
+89% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
36% FFS 64% MCO
Fee-for-service · 737 Rx Managed care · 1,307 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: 880 units · 8.8 per 100k residents MI New York: 8,035 units · 41.1 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 6,285 units · 50.1 per 100k residents IL Indiana: no data reported IN Ohio: 1,372 units · 11.6 per 100k residents OH Pennsylvania: 123,625 units · 954 per 100k residents PA New Jersey: 100 units · 1.1 per 100k residents NJ Massachusetts: no data reported MA California: 26,800 units · 68.8 per 100k residents CA Utah: no data reported UT Colorado: 682 units · 11.6 per 100k residents CO Nebraska: no data reported NE Missouri: 1,937 units · 31.3 per 100k residents MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: 951 units · 18.6 per 100k residents AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 11,575 units · 37.9 per 100k residents TX Florida: 793 units · 3.5 per 100k residents FL
Units reimbursed · per 100k residents
1.1954
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Pennsylvania 954 /100k
2 California 68.8 /100k
3 Illinois 50.1 /100k
4 New York 41.1 /100k
5 Texas 37.9 /100k
6 Missouri 31.3 /100k
7 Alabama 18.6 /100k
8 Ohio 11.6 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
100 tablets this page00832-0513-00 2,044 Rx · $94,310
100 tablets00832-0513-01 No Medicaid data
1000 tablets00832-0513-10 No Medicaid data
500 tablets00832-0513-50 No Medicaid data
Drug total (last 4 qtrs): 2,044 Rx · 184,384 units · $94,310 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Bethanechol Chloride — the program that covers self-administered drugs. 6 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Bethanechol Chloride. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$2.4M
Claims incl. refills
46.7K
Beneficiaries
25K
Spend / beneficiary
$96.05
Spend / claim
$51.28
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Bethanechol Chloride — the ingredient across all brands.

Top reported reactions

Fall36
Death34
Urinary Tract Infection34
Fatigue33
Pneumonia31
Diarrhoea29
Dizziness27

Age at onset

Infant1
Child3
Adolescent3
Adult49
Elderly55

Reporter sex

546 reports
Male · 44%
Female · 56%

Serious outcomes

Hospitalization226
Death84
Life-threatening21
Disabling9
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 55 29
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00832-0512-00 · Upsher-Smith 00832-0532-09 · Upsher-Smith →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.